Harvard Bioscience, Inc. (HBIO) vs Precipio, Inc. (PRPO)
A side-by-side comparison of Harvard Bioscience, Inc. and Precipio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HBIO
Harvard Bioscience, Inc.
$8.67HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
PRPO
Precipio, Inc.
$23.50HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
Total return — HBIO vs PRPO
growth of $100 · dividends reinvested · last 9yHBIO -66.7% (-11.5%/yr)PRPO -99.1% (-40.8%/yr)HBIO compounded faster over this window
Log scale — wide-divergence pair
HBIO PRPO
HBIO vs PRPO: by the numbers
- •PRPO is the larger company ($42M vs $39M market cap).
- •Both run net losses; PRPO's is the smaller (-4.42% vs -11.86% net margin).
- •PRPO grew revenue faster over the past five years (28.84% vs -4.62% CAGR).
Metrics side by side
Valuation
| Metric | HBIO | PRPO |
|---|---|---|
| P/S ratio | 0.45 | 1.53 |
| P/B ratio | 5.27 | 2.84 |
| EV / EBITDA | 10.61 | N/A |
| FCF yield | N/A | 1.88% |
Profitability
| Metric | HBIO | PRPO |
|---|---|---|
| Gross margin | 58.16% | 43.69% |
| Operating margin | 1.17% | -5.63% |
| Net margin | -11.86% | -4.42% |
| ROE | -140.36% | -8.23% |
| ROIC | 1.99% | -8.43% |
Growth (annualized)
| Metric | HBIO | PRPO |
|---|---|---|
| Revenue CAGR (5Y) | -4.62% | 28.84% |
| Total return CAGR (5Y) | -34.33% | -14.46% |
Frequently asked
- Which has grown faster, HBIO or PRPO?
- Over the past five years, PRPO grew revenue faster — HBIO at a -4.62% CAGR versus PRPO at 28.84%.
- How have HBIO and PRPO total returns compared?
- Over the past 5 years, HBIO delivered -34.33% and PRPO delivered -14.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Harvard Bioscience ROEPrecipio ROEHarvard Bioscience operating marginPrecipio operating marginHarvard Bioscience revenue growthPrecipio revenue growthHarvard Bioscience free cash flowPrecipio free cash flow
Harvard Bioscience & Precipio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.